Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Doxycycline or flucloxacillin can cause a rare, severe skin reaction that can be fatal, especially in the elderly.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

Some antidepressants can cause rare hair loss, which can significantly affect patients' well-being.

A new side effect of aromatic retinoid treatment is soft nails.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

The lotion and shampoo effectively treated scalp seborrheic dermatitis.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Ascorbic acid, orlistat, and mastic gum can effectively reduce sweat odor.

High consumption of avocado leaves harms male fertility.

Midazolam reduces PTSD-like behavior in rats by acting on specific brain receptors.

Finasteride must now warn about lasting sexual side effects.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Semaglutide may help some skin disorders but can also cause skin issues.

Sertraline, an antidepressant, may cause hair loss in rare cases.

Isotretinoin can cause gynecomastia by lowering testosterone levels.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Finasteride can help with hair loss and prostate issues but may negatively affect mood and the nervous system.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Flutamide rarely causes liver toxicity in prostate cancer patients.